Fibrinogen-like globe domain of human Tenascin-C (hFBG-C); A Target Enabling Package

Jesse A. Coker, Anna M. Marzeda, Anja Schwenzer, Brian D. Marsden, Kim S. Midwood, Wyatt W. YueZenodo 2020 · DOI · OpenAlex

Abstract

Chronic activation of the innate immune system by the damage-associated molecular pattern FBG-C (C-terminal fibrinogen-like globe domain of Tenascin-C) contributes to a variety of inflammatory diseases including arthritis, systemic sclerosis, and cancer. This TEP summarizes the first reported efforts to develop small-molecule FBG-C binders, with the aim to disrupt FBG-C-mediated pro-inflammatory protein-protein interactions (PPIs). We present the soluble expression of disulphide-containing human FBG-C (hFBG-C) in <em>E. coli</em>, the novel structure of hFBG-C, and preliminary chemical matter against hFBG-C derived from a crystallographic fragment screen. Finally, we introduce two robustly validated cellular assays, in either immortalized monocytes or primary human macrophages, which provide a route to development of small molecules which inhibit hFBG-C-activated inflammation.
BibTeX
@inproceedings{coker2020fibrinogen,
  author = {Jesse A. Coker and Anna M. Marzeda and Anja Schwenzer and Brian D. Marsden and Kim S. Midwood and Wyatt W. Yue and Brian Marsden},
  title = {{Fibrinogen-like globe domain of human Tenascin-C (hFBG-C); A Target Enabling Package}},
  booktitle = {Zenodo},
  year = {2020},
  doi = {10.5281/zenodo.4429107},
}

Loading related content...

Figure